Ocera Therapeutics, Inc.
OCRX
OCRX was delisted on the 8th of December, 2017.
18 hedge funds and large institutions have $44.6M invested in Ocera Therapeutics, Inc. in 2013 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.
660% more capital invested
Capital invested by funds: $5.87M → $44.6M (+$38.7M)
400% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 2
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
80% more funds holding
Funds holding: 10 → 18 (+8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VM
VHCP Management
New York
|
+$6.57M |
| 2 |
QF
QVT Financial
New York
|
+$5.92M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$4.93M |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$4.16M |
| 5 |
DM
Deerfield Management
New York
|
+$1.97M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$11K |
| 2 |
U
UBS
Zurich,
Switzerland
|
-$3K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.72K |
OCRX Hedge Fund Activity: Q4 2013 in Review
18 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in Ocera Therapeutics, Inc. (OCRX) for Q4 2013, worth a combined $44.6M — up 660% from $5.87M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new OCRX positions and 2 closed out — a net gain of 8 holders — while 5 added to existing stakes and 1 trimmed.
The largest buyer was VHCP Management, opening a new position worth an estimated $6.57M. The largest seller was Dimensional Fund Advisors, exiting entirely with an estimated $11K sold.
- 18 institutional investors held Ocera Therapeutics, Inc. (OCRX) as of Q4 2013, up from 10 in Q3 2013.
- Funds reported $44.6M of Ocera Therapeutics, Inc. stock for Q4 2013, up 660% quarter-over-quarter.
- 10 funds opened new Ocera Therapeutics, Inc. positions in Q4 2013 and 2 closed out, a net change of +8 holders.
- The largest Ocera Therapeutics, Inc. buyer in Q4 2013 was VHCP Management, an estimated $6.57M added.
- The largest Ocera Therapeutics, Inc. seller in Q4 2013 was Dimensional Fund Advisors, an estimated $11K sold.
Based on aggregated 13F filings for Q4 2013.